Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia

Theodore Graber, Brandy L. Rawls, Bing Tian, William J. Durham, Camille R. Brightwell, Allan R. Brasier, Blake Rasmussen, Christopher Fry

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Due to immunosenescence, older adults are particularly susceptible to lung-based viral infections, with increased severity of symptoms in those with underlying chronic lung disease. Repeated respiratory viral infections produce lung maladaptations, accelerating pulmonary dysfunction. Toll like 3 receptor (TLR3) is a membrane protein that senses exogenous double-stranded RNA to activate the innate immune response to a viral infection. Polyinosinic-polycytidylic acid [poly(I:C)] mimics double stranded RNA and has been shown to activate TLR3. Utilizing an established mouse viral exacerbation model produced by repetitive intranasal poly(I:C) administration, we sought to determine whether repetitive poly(I:C) treatment induced negative muscle adaptations (i.e. atrophy, weakness, and loss of function). We determined skeletal muscle morphological properties (e.g. fiber-type, fiber cross-sectional area, muscle wet mass, etc.) from a treated group ((poly(I:C), n = 9) and a sham-treated control group (PBS, n = 9); age approximately 5 months. In a subset (n = 4 for both groups), we determined in vivo physical function (using grip test for strength, rotarod for overall motor function, and treadmill for endurance) and muscle contractile properties with in vitro physiology (in the EDL, soleus and diaphragm). Our findings demonstrate that poly(I:C)-treated mice exhibit both muscle morphological and functional deficits. Changes of note when comparing poly(I:C)-treated mice to PBS-treated controls include reductions in fiber cross-sectional area (−27% gastrocnemius, −25% soleus, −16% diaphragm), contractile dysfunction (soleus peak tetanic force, −26%), muscle mass (gastrocnemius −19%, soleus −23%), physical function (grip test −34%), body mass (−20%), and altered oxidative capacity (140% increase in succinate dehydrogenase activity in the diaphragm, but 66% lower in the gastrocnemius). Our data is supportive of a new model of cachexia/sarcopenia that has potential for future research into the mechanisms underlying muscle wasting.

Original languageEnglish (US)
Pages (from-to)88-100
Number of pages13
JournalExperimental Gerontology
Volume106
DOIs
StatePublished - Jun 1 2018

Fingerprint

Poly I-C
Cachexia
Muscle
Skeletal Muscle
Chemical activation
Lung
Virus Diseases
Muscles
Diaphragm
Diaphragms
Double-Stranded RNA
Hand Strength
Fibers
Rotarod Performance Test
Toll-Like Receptor 3
Sarcopenia
Succinate Dehydrogenase
Exercise equipment
Pulmonary diseases
Innate Immunity

Keywords

  • Ageing
  • COPD cachexia
  • Mouse models
  • Physical function
  • Skeletal muscle
  • TLR3

ASJC Scopus subject areas

  • Biochemistry
  • Aging
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology

Cite this

Graber, T., Rawls, B. L., Tian, B., Durham, W. J., Brightwell, C. R., Brasier, A. R., ... Fry, C. (2018). Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia. Experimental Gerontology, 106, 88-100. https://doi.org/10.1016/j.exger.2018.02.002

Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia. / Graber, Theodore; Rawls, Brandy L.; Tian, Bing; Durham, William J.; Brightwell, Camille R.; Brasier, Allan R.; Rasmussen, Blake; Fry, Christopher.

In: Experimental Gerontology, Vol. 106, 01.06.2018, p. 88-100.

Research output: Contribution to journalArticle

Graber, Theodore ; Rawls, Brandy L. ; Tian, Bing ; Durham, William J. ; Brightwell, Camille R. ; Brasier, Allan R. ; Rasmussen, Blake ; Fry, Christopher. / Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia. In: Experimental Gerontology. 2018 ; Vol. 106. pp. 88-100.
@article{8785a02343a1477ca1e5f3776733364c,
title = "Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia",
abstract = "Due to immunosenescence, older adults are particularly susceptible to lung-based viral infections, with increased severity of symptoms in those with underlying chronic lung disease. Repeated respiratory viral infections produce lung maladaptations, accelerating pulmonary dysfunction. Toll like 3 receptor (TLR3) is a membrane protein that senses exogenous double-stranded RNA to activate the innate immune response to a viral infection. Polyinosinic-polycytidylic acid [poly(I:C)] mimics double stranded RNA and has been shown to activate TLR3. Utilizing an established mouse viral exacerbation model produced by repetitive intranasal poly(I:C) administration, we sought to determine whether repetitive poly(I:C) treatment induced negative muscle adaptations (i.e. atrophy, weakness, and loss of function). We determined skeletal muscle morphological properties (e.g. fiber-type, fiber cross-sectional area, muscle wet mass, etc.) from a treated group ((poly(I:C), n = 9) and a sham-treated control group (PBS, n = 9); age approximately 5 months. In a subset (n = 4 for both groups), we determined in vivo physical function (using grip test for strength, rotarod for overall motor function, and treadmill for endurance) and muscle contractile properties with in vitro physiology (in the EDL, soleus and diaphragm). Our findings demonstrate that poly(I:C)-treated mice exhibit both muscle morphological and functional deficits. Changes of note when comparing poly(I:C)-treated mice to PBS-treated controls include reductions in fiber cross-sectional area (−27{\%} gastrocnemius, −25{\%} soleus, −16{\%} diaphragm), contractile dysfunction (soleus peak tetanic force, −26{\%}), muscle mass (gastrocnemius −19{\%}, soleus −23{\%}), physical function (grip test −34{\%}), body mass (−20{\%}), and altered oxidative capacity (140{\%} increase in succinate dehydrogenase activity in the diaphragm, but 66{\%} lower in the gastrocnemius). Our data is supportive of a new model of cachexia/sarcopenia that has potential for future research into the mechanisms underlying muscle wasting.",
keywords = "Ageing, COPD cachexia, Mouse models, Physical function, Skeletal muscle, TLR3",
author = "Theodore Graber and Rawls, {Brandy L.} and Bing Tian and Durham, {William J.} and Brightwell, {Camille R.} and Brasier, {Allan R.} and Blake Rasmussen and Christopher Fry",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.exger.2018.02.002",
language = "English (US)",
volume = "106",
pages = "88--100",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia

AU - Graber, Theodore

AU - Rawls, Brandy L.

AU - Tian, Bing

AU - Durham, William J.

AU - Brightwell, Camille R.

AU - Brasier, Allan R.

AU - Rasmussen, Blake

AU - Fry, Christopher

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Due to immunosenescence, older adults are particularly susceptible to lung-based viral infections, with increased severity of symptoms in those with underlying chronic lung disease. Repeated respiratory viral infections produce lung maladaptations, accelerating pulmonary dysfunction. Toll like 3 receptor (TLR3) is a membrane protein that senses exogenous double-stranded RNA to activate the innate immune response to a viral infection. Polyinosinic-polycytidylic acid [poly(I:C)] mimics double stranded RNA and has been shown to activate TLR3. Utilizing an established mouse viral exacerbation model produced by repetitive intranasal poly(I:C) administration, we sought to determine whether repetitive poly(I:C) treatment induced negative muscle adaptations (i.e. atrophy, weakness, and loss of function). We determined skeletal muscle morphological properties (e.g. fiber-type, fiber cross-sectional area, muscle wet mass, etc.) from a treated group ((poly(I:C), n = 9) and a sham-treated control group (PBS, n = 9); age approximately 5 months. In a subset (n = 4 for both groups), we determined in vivo physical function (using grip test for strength, rotarod for overall motor function, and treadmill for endurance) and muscle contractile properties with in vitro physiology (in the EDL, soleus and diaphragm). Our findings demonstrate that poly(I:C)-treated mice exhibit both muscle morphological and functional deficits. Changes of note when comparing poly(I:C)-treated mice to PBS-treated controls include reductions in fiber cross-sectional area (−27% gastrocnemius, −25% soleus, −16% diaphragm), contractile dysfunction (soleus peak tetanic force, −26%), muscle mass (gastrocnemius −19%, soleus −23%), physical function (grip test −34%), body mass (−20%), and altered oxidative capacity (140% increase in succinate dehydrogenase activity in the diaphragm, but 66% lower in the gastrocnemius). Our data is supportive of a new model of cachexia/sarcopenia that has potential for future research into the mechanisms underlying muscle wasting.

AB - Due to immunosenescence, older adults are particularly susceptible to lung-based viral infections, with increased severity of symptoms in those with underlying chronic lung disease. Repeated respiratory viral infections produce lung maladaptations, accelerating pulmonary dysfunction. Toll like 3 receptor (TLR3) is a membrane protein that senses exogenous double-stranded RNA to activate the innate immune response to a viral infection. Polyinosinic-polycytidylic acid [poly(I:C)] mimics double stranded RNA and has been shown to activate TLR3. Utilizing an established mouse viral exacerbation model produced by repetitive intranasal poly(I:C) administration, we sought to determine whether repetitive poly(I:C) treatment induced negative muscle adaptations (i.e. atrophy, weakness, and loss of function). We determined skeletal muscle morphological properties (e.g. fiber-type, fiber cross-sectional area, muscle wet mass, etc.) from a treated group ((poly(I:C), n = 9) and a sham-treated control group (PBS, n = 9); age approximately 5 months. In a subset (n = 4 for both groups), we determined in vivo physical function (using grip test for strength, rotarod for overall motor function, and treadmill for endurance) and muscle contractile properties with in vitro physiology (in the EDL, soleus and diaphragm). Our findings demonstrate that poly(I:C)-treated mice exhibit both muscle morphological and functional deficits. Changes of note when comparing poly(I:C)-treated mice to PBS-treated controls include reductions in fiber cross-sectional area (−27% gastrocnemius, −25% soleus, −16% diaphragm), contractile dysfunction (soleus peak tetanic force, −26%), muscle mass (gastrocnemius −19%, soleus −23%), physical function (grip test −34%), body mass (−20%), and altered oxidative capacity (140% increase in succinate dehydrogenase activity in the diaphragm, but 66% lower in the gastrocnemius). Our data is supportive of a new model of cachexia/sarcopenia that has potential for future research into the mechanisms underlying muscle wasting.

KW - Ageing

KW - COPD cachexia

KW - Mouse models

KW - Physical function

KW - Skeletal muscle

KW - TLR3

UR - http://www.scopus.com/inward/record.url?scp=85043399789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043399789&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2018.02.002

DO - 10.1016/j.exger.2018.02.002

M3 - Article

C2 - 29452288

AN - SCOPUS:85043399789

VL - 106

SP - 88

EP - 100

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

ER -